Effects of Saiko-ka-ryukotsu-borei-to in patients with hyperlipidemia

Phytomedicine

Volumn 8, Issue 3, 2001, Pages 165-173

  Nomura, S ^a   Hattori, N ^b   Sakakibara, I ^b   Fukuhara, S ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b TSUMURA AND CO   (Japan)

Author keywords

Anti oxidized LDL antibody; Hyperlipidemia; Platelet derived microparticle; Saiko ka ryukotsu borei to; Soluble E selectin

Indexed keywords

CD36 ANTIGEN; CD40 ANTIGEN; CHOLESTEROL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRINOGEN RECEPTOR; GLYCOPROTEIN IB; MONOCLONAL ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; PADGEM PROTEIN; PROTEIN ANTIBODY; SAIKO KA RYUKOTSU BOREI TO; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN BINDING; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HYPERLIPIDEMIA; MALE; MEASUREMENT; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR DISEASE;

EID: 0034981945     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1078/0944-7113-00035     Document Type: Article

References (49)

1. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina: Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes
2. Modulation by high glucose of adhesion molecule expression in cultured endothelial cells
3. Monocyte adherence to human vascular endothelium
4. Autoantibodies against oxidatively modified low-density lipoproteins in NIDDM
5. Minimally modified low density lipoproteins stimulates monocyte endothelial interactions
6. Endothelial-leukocyte adhesion molecules
7. Single risk factor intervention may be inadequate to inhibit atherosclerosis progression when hypertension and hypercholesterolemia co-exist
8. Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: Relation to metabolic control
9. Leukocyte and platelet function and eicosanoid production in subjects with hypercholesterolaemia
10. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells
11. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM-1, and E-selectin in human atheroscrelosis
12. Functional tissue factor is entirely surface expressed on lipopolysaccharide stimulated human blood monocytes and a constitutively tissue factor producing neoplastic cell line
13. Minimally oxidized LDL induces tissue factor expression in cultured human endothelial cells
14. Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in macrophages
15. Expression of VCAM-1 and E-selectin in an in vivo model of endothelial activation
16. Mechanisms of monocyte recruitment and accumulation
17. The molecular basis of blood coagulation
18. Monocytes and macrophages
19. Regional accumlation of T cells, macrophages, and smooth muscle cells in the human athero-sclerotic plaque
20. Defective expression of CD40 ligand on T cells causes X-linked immunodeficiency with hyper-IgM (HIGM1)
21. Plasma lipids and platelet membrane fluidity in essential hypertension
22. Atheroma: More than mush
23. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: Induction of collagenase, etromelysin, and tissue factor
24. Endothelial cell activation by leukocyte microparticles
25. Effect of a new monoclonal anti-glyco- protein IX antibody, KMP-9, on high shear-induced platelet aggregation
26. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles
27. Flow cytometric analysis of platelet activation markers CD62P and CD63 in patients with coronary artery disease
28. Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets
29. Effects of EDTA on membrane glycoprotein IIb-IIIa complex: Analysis using flow cytometry
30. Differences between platelet and microparticle glycoprotein IIb/IIIa
31. Amyloid β-protein precursor-rich platelet microparticles in thrombotic disease
32. Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus
33. Procoagulant and profibrinolytic activities of cryopreserved human monovytes
34. The role of platelets in the development and complications of atherosclerosis
35. Induction of endothelial celexpression of granulocyte and macrophage colony-stimulating factors by modified low density lipoproteins
36. The pathogenesis of atherosclerosis: A perspective study for the 1990s
37. Endotoxin enhances the expression of monocyte prothrombinase activity
38. Autoantibody against oxidised LDL and progression of carotid atherosclerosis
39. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity
40. A macrophage receptor that recognizes oxidized LDL but not acetylated LDL
41. Adhesion receptors of the immune system
42. Increased levels of soluble adhesion molecules in type 2 (non-insulin dependent) diabetes mellitus are independent of glycaemic control
43. Flow cytometric detection of surface membrane alterations and concomitant changes in the cytoskeletal actins status of activated platelets
44. Thrombin induces platelet adhesion to endothelial cells
45. Activated platelets signal chemokine synthesiss by human monocytes
46. Localization of tissue factor in normal vessel wall and in the atherosclerotic plaque
47. Annexin V expression and membrane vesiculation during activation of leukemic cell lines
48. Pathological analysis on the effects of traditional chinese drugs in spontaneously hypertensive rats (SHR) aorta
49. Tyrosine Phosphorylation and p72syk activation by an anti-glycoprotein Ib monoclonal antibody